Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Labat AfricaJSE:LAB 3-Year FCF Growth Rate is 4.10% as of Nov. 2025, which is 72% below its 10-year median of 14.40. The stock has 8 warning signs investors should review. Among 659 Drug Manufacturers companies, Labat Africa ranks worse than 54.63% on this metric.
During the past 12 months, Labat Africa's average Free Cash Flow per Share Growth Rate was 140.00% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 4.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Labat Africa was 143.80% per year. The lowest was -78.50% per year. And the median was 14.40% per year.
Labat Africa (JSE:LAB) 3-Year FCF Growth Rate Explanation
Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.
Labat Africa 3-Year FCF Growth Rate Related Terms
JSE:LAB vs ZTS, UTHR, VTRS: 3-Year FCF Growth Rate Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Labat Africa's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labat Africa 3-Year FCF Growth Rate vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Labat Africa's 3-Year FCF Growth Rate distribution charts can be found below:
* The bar in red indicates where Labat Africa's 3-Year FCF Growth Rate falls into.
This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.
Labat Africa (JSE:LAB) has a 3-Year FCF Growth Rate of 4.10% as of Nov. 2025. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Labat Africa and its competitors. This is 72% below median its historical median of 14.40. According to the industry distribution chart, Labat Africa ranks #360 out of 659 companies in the Drug Manufacturers industry, placing it in the top 54.6%.
Is Labat Africa's 3-Year FCF Growth Rate too high?
Labat Africa's current 3-Year FCF Growth Rate of 4.10% is 72% below median its 10-year median of 14.40. The Drug Manufacturers industry median 3-Year FCF Growth Rate is 8.90. Labat Africa's value of 4.10% is 53.9% below this industry median. Based on the distribution chart, Labat Africa ranks #360 out of 659 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does Labat Africa's 3-Year FCF Growth Rate compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Labat Africa ranks #360 out of 659 companies for 3-Year FCF Growth Rate. This places Labat Africa in the lower half of its industry. The industry median 3-Year FCF Growth Rate is 8.90. Labat Africa's value of 4.10% is 53.9% below this benchmark. While the company's 10-year median is 14.40 vs. the industry median of 8.90, Labat Africa has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year FCF Growth Rate for a Drug Manufacturers company?
The median 3-Year FCF Growth Rate among Drug Manufacturers companies is 8.90, based on 659 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year FCF Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year FCF Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Labat Africa's current 3-Year FCF Growth Rate of 4.10% is 53.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year FCF Growth Rate mean?
A high 3-Year FCF Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year FCF Growth Rate is the 3-year average growth rate of Free Cash Flow per Share. View historical data for Labat Africa and its competitors. For the Drug Manufacturers industry, the median 3-Year FCF Growth Rate is 8.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labat Africa's current 3-Year FCF Growth Rate is 4.10%, which is 72% below median its own 10-year median of 14.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labat Africa stock overvalued right now?
Based on GuruFocus' analysis, Labat Africa (JSE:LAB) is currently considered Possible Value Trap. The stock's GF Value™ is R0.22, compared to a current price of R0.03 — trading 86.4% below its estimated fair value. The current 3-Year FCF Growth Rate is 4.10%, which is 72% below median its 10-year median of 14.40 and 53.9% below the Drug Manufacturers industry median of 8.90. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year FCF Growth Rate calculated?
3-Year FCF Growth Rate is calculated from a company's financial statements. For Labat Africa (JSE:LAB), the current 3-Year FCF Growth Rate is 4.10% as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Labat Africa Ltd is an investment holding company. Through its subsidiaries, the company operates in the following segments; Technology, Head office, and Healthcare. The Technology segment manufactures and distributes integrated circuits South African Micro - Electronic Systems. Head office operations provide management services, logistics and seeks further investment opportunities for the Group. The Healthcare segment generates maximum revenue for the company and focusses on medical cannabis industry in South Africa. Geographically, the company carries out its business operations in South Africa.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JSE:LAB has been successfully added to your 
